EMC Capital Management’s Moderna MRNA Stock Holding History

EMC Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,500	Closed	-$65K	–	310
2025 Q3	$65K	Sell	2,500 -6,500	-72%	-$181K	0.03%	242
2025 Q2	$248K	Buy	9,000 +3,000	+50%	+$79K	0.13%	52
2025 Q1	$165K	Buy	6,000 +4,750	+380%	+$169K	0.1%	174
2024 Q4	$52K	Buy	1,250 +946	+311%	+$45.2K	0.03%	253
2024 Q3	$176K	Sell	304 -696	-70%	-$63.9K	0.12%	180
2024 Q2	$117K	Hold	1,000	–	–	0.07%	225
2024 Q1	$105K	Hold	1,000	–	–	0.06%	241
2023 Q4	$99K	Hold	1,000	–	–	0.07%	225
2023 Q3	$104K	Sell	1,000 -18,814	-95%	-$2.1M	0.08%	217
2023 Q2	$313	Buy	19,814 +17,814	+891%	+$2.38M	0.24%	66
2023 Q1	$313K	Hold	2,000	–	–	0.26%	64
2022 Q4	$359K	Hold	2,000	–	–	0.32%	42
2022 Q3	$358K	Hold	2,000	–	–	0.33%	28
2022 Q2	$358K	Hold	2,000	–	–	0.31%	33
2022 Q1	$345K	Hold	2,000	–	–	0.25%	47
2021 Q4	$508K	Hold	2,000	–	–	0.27%	71
2021 Q3	$690K	Hold	2,000	–	–	0.39%	68
2021 Q2	$827K	Hold	2,000	–	–	0.47%	60
2021 Q1	$262K	Buy	2,000 +1,000	+100%	+$145K	0.19%	86
2020 Q4	$104K	Buy	+1,000	New	+$101K	0.08%	94

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EMC Capital Management's MRNA Position: Q4 2025 in Review

EMC Capital Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 2,500 shares — an estimated $65K sold.

EMC Capital Management first reported a position in MRNA in Q4 2020 and held it in 20 quarters. The position peaked at $827K in Q2 2021. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

EMC Capital Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
EMC Capital Management sold 2,500 Moderna shares in Q4 2025, an estimated $65K.
EMC Capital Management first reported a position in Moderna in Q4 2020 and held it in 20 quarters.
EMC Capital Management's Moderna position peaked at $827K in Q2 2021.
672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.